$MNKD
MANNKIND CORP

2014 Q3 Form 10-Q Financial Statement

#000119312514305043 Filed on August 11, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2014 Q2 2013 Q2
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $19.10M $32.50M $14.50M
YoY Change 9.14% 124.14% 49.48%
% of Gross Profit
Research & Development $19.18M $37.32M $27.05M
YoY Change -29.7% 37.97% 1.55%
% of Gross Profit
Depreciation & Amortization $2.449M $2.449M $2.956M
YoY Change -14.79% -17.15% -10.53%
% of Gross Profit
Operating Expenses $38.27M $69.85M $41.59M
YoY Change -14.51% 67.96% -5.6%
Operating Profit -$38.27M -$69.85M -$41.59M
YoY Change -14.51% 67.96% -5.6%
Interest Expense -$6.200M -$3.100M -$4.600M
YoY Change 1.64% -32.61% -22.03%
% of Operating Profit
Other Income/Expense, Net $7.898M -$370.0K $15.00K
YoY Change 78880.0% -2566.67% -99.89%
Pretax Income -$36.52M -$73.37M -$46.12M
YoY Change -28.14% 59.06% 26.1%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$36.52M -$73.37M -$46.12M
YoY Change -28.14% 59.06% 26.1%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$463.2K -$892.9K -$811.6K
COMMON SHARES
Basic Shares Outstanding 402.4M shares 388.6M shares 290.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q3 2014 Q2 2013 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $172.5M $41.20M $28.50M
YoY Change 83.9% 44.56% -10.94%
Cash & Equivalents $172.5M $41.21M $28.53M
Short-Term Investments $25.90M
Other Short-Term Assets $20.30M $3.700M $3.200M
YoY Change 290.38% 15.63% -82.61%
Inventory
Prepaid Expenses $15.00M
Receivables
Other Receivables
Total Short-Term Assets $193.5M $44.91M $32.16M
YoY Change 94.83% 39.64% -36.06%
LONG-TERM ASSETS
Property, Plant & Equipment $190.9M $183.5M $179.6M
YoY Change 7.36% 2.21% -5.09%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.114M $7.400M $230.0K
YoY Change -79.33% 3117.39% -74.44%
Total Long-Term Assets $193.3M $191.4M $180.3M
YoY Change 2.67% 6.17% -5.17%
TOTAL ASSETS
Total Short-Term Assets $193.5M $44.91M $32.16M
Total Long-Term Assets $193.3M $191.4M $180.3M
Total Assets $386.8M $236.3M $212.4M
YoY Change 34.49% 11.24% -11.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $17.39M $5.086M $5.419M
YoY Change 123.34% -6.15% -6.57%
Accrued Expenses $27.27M $20.58M $26.98M
YoY Change 26.52% -23.74% -34.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $37.70M $119.6M
YoY Change -100.0% -68.48%
Long-Term Debt Due $99.10M $114.7M
YoY Change -13.75%
Total Short-Term Liabilities $293.8M $119.2M $266.8M
YoY Change 35.28% -55.31% 381.56%
LONG-TERM LIABILITIES
Long-Term Debt $122.1M $148.4M $98.00M
YoY Change -43.97% 51.43% -77.17%
Other Long-Term Liabilities $11.57M $15.04M
YoY Change -43.01%
Total Long-Term Liabilities $11.57M $15.04M $98.00M
YoY Change -43.01% -84.65% -77.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $293.8M $119.2M $266.8M
Total Long-Term Liabilities $11.57M $15.04M $98.00M
Total Liabilities $427.5M $282.7M $364.8M
YoY Change -6.11% -22.51% -24.76%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $2.418B $2.375B $2.040B
YoY Change 16.51% 16.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$40.68M -$46.38M -$152.4M
YoY Change
Total Liabilities & Shareholders Equity $386.8M $236.3M $212.4M
YoY Change 34.49% 11.24% -11.64%

Cashflow Statement

Concept 2014 Q3 2014 Q2 2013 Q2
OPERATING ACTIVITIES
Net Income -$36.52M -$73.37M -$46.12M
YoY Change -28.14% 59.06% 26.1%
Depreciation, Depletion And Amortization $2.449M $2.449M $2.956M
YoY Change -14.79% -17.15% -10.53%
Cash From Operating Activities $100.2M -$23.42M -$29.74M
YoY Change -404.59% -21.25% 18.91%
INVESTING ACTIVITIES
Capital Expenditures -$9.460M -$8.260M -$130.0K
YoY Change 4013.04% 6253.85% 0.0%
Acquisitions
YoY Change
Other Investing Activities $9.250M $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$210.0K -$8.260M -$130.0K
YoY Change -8.7% 6253.85% 44.44%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 31.23M 37.13M 30.40M
YoY Change -68.27% 22.14% 7694.87%
NET CHANGE
Cash From Operating Activities 100.2M -23.42M -29.74M
Cash From Investing Activities -210.0K -8.260M -130.0K
Cash From Financing Activities 31.23M 37.13M 30.40M
Net Change In Cash 131.3M 5.450M 530.0K
YoY Change 101.07% 928.3% -102.14%
FREE CASH FLOW
Cash From Operating Activities $100.2M -$23.42M -$29.74M
Capital Expenditures -$9.460M -$8.260M -$130.0K
Free Cash Flow $109.7M -$15.16M -$29.61M
YoY Change -435.68% -48.8% 19.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
402380752 shares
CY2013Q2 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28529000
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
394036984 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
394036984 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2014Q2 us-gaap Ownshare Lending Arrangement Shares Outstanding
OwnshareLendingArrangementSharesOutstanding
9000000 shares
CY2014Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2014Q2 us-gaap Ownshare Lending Arrangement Shares Issued
OwnshareLendingArrangementSharesIssued
9000000 shares
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
2000000
CY2014Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
115799000
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
119233000
CY2014Q2 us-gaap Other Long Term Debt Noncurrent
OtherLongTermDebtNoncurrent
37744000
CY2014Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
49521000
CY2014Q2 us-gaap Interest Payable Current
InterestPayableCurrent
2396000
CY2014Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
55824000
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
3964000
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
CY2014Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
5086000
CY2014Q2 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
37744000
CY2014Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
98889000
CY2014Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2371487000
CY2014Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20579000
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
-46377000
CY2014Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15040000
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4205000
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
236306000
CY2014Q2 us-gaap Liabilities
Liabilities
282683000
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9745000
CY2014Q2 us-gaap Construction Payable Current
ConstructionPayableCurrent
2812000
CY2014Q2 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
30100000
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41214000
CY2014Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
41100000
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
183533000
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3696000
CY2014Q2 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
2421824000
CY2014Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
299332000
CY2014Q2 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
463000
CY2014Q2 us-gaap Assets
Assets
236306000
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
7400000
CY2014Q2 us-gaap Assets Current
AssetsCurrent
44910000
CY2014Q2 mnkd Loan Commitment Asset Noncurrent Portion
LoanCommitmentAssetNoncurrentPortion
6910000
CY2014Q2 mnkd Preferred Stock Shares Undesignated
PreferredStockSharesUndesignated
10000000 shares
CY2014Q2 mnkd Available Borrowings Under Loan Agreement
AvailableBorrowingsUnderLoanAgreement
0
CY2014Q2 mnkd Loan Commitment Asset
LoanCommitmentAsset
5157000
CY2014Q2 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2014Q2 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
463000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4000
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3860000
CY2013Q4 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
102300000
CY2013Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
98439000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2261996000
CY2013Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21634000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-30713000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13605000
CY2014Q2 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
1421000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61840000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
369391972 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
369391972 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
550000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
111060000
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
127794000
CY2013Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
49521000
CY2013Q4 us-gaap Interest Payable Current
InterestPayableCurrent
2082000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
3697000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
5706000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
258646000
CY2013Q4 us-gaap Liabilities
Liabilities
289359000
CY2013Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
12193000
CY2013Q4 us-gaap Construction Payable Current
ConstructionPayableCurrent
342000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70790000
CY2013Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
67700000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
176557000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5485000
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
2296402000
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
287617000
CY2013Q4 us-gaap Nontrade Receivables Noncurrent
NontradeReceivablesNoncurrent
298000
CY2013Q4 us-gaap Assets
Assets
258646000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
5516000
CY2013Q4 us-gaap Assets Current
AssetsCurrent
76275000
CY2013Q4 mnkd Estimated Amounts Credit Exchange Receivable
EstimatedAmountsCreditExchangeReceivable
298000
CY2013Q4 mnkd Common Stock Loaned Under Share Lending Agreement Shares
CommonStockLoanedUnderShareLendingAgreementShares
9000000 shares
CY2013Q4 mnkd Accrued Research And Clinical Trial Costs
AccruedResearchAndClinicalTrialCosts
1311000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-61771000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
282062000 shares
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.31
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
129432728 shares
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1337000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-87089000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
us-gaap Operating Income Loss
OperatingIncomeLoss
-78022000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-87091000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
38000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-2000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1591000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
2000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-87089000
us-gaap Net Income Loss
NetIncomeLoss
-87089000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
us-gaap Interest Paid
InterestPaid
5006000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
448000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
4605000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
15362000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5946000
us-gaap Operating Expenses
OperatingExpenses
78022000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
3378000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
421000
us-gaap Interest Expense Debt
InterestExpenseDebt
5729000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-33311000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2398000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
6668000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
30051000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-1591000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
53450000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24572000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-974000
us-gaap Share Based Compensation
ShareBasedCompensation
15362000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-157000
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-686000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
30499000
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
MANNKIND CORP
dei Trading Symbol
TradingSymbol
MNKD
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y11D
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-60408000
us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.85 pure
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
374810000 shares
dei Document Period End Date
DocumentPeriodEndDate
2014-06-30
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Entity Central Index Key
EntityCentralIndexKey
0000899460
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.33
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1789000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
131000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-125422000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
123000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
2965000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
51583000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4972000
us-gaap Operating Expenses
OperatingExpenses
111258000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1435000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
450000
us-gaap Interest Expense Debt
InterestExpenseDebt
6471000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-29576000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3315000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
56844341 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
-111258000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-125422000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
93500000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6260000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9667000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-125422000
us-gaap Net Income Loss
NetIncomeLoss
-125422000
us-gaap Investment Income Interest
InvestmentIncomeInterest
2000
us-gaap Interest Paid
InterestPaid
5296000
mnkd Nominal Lending Fee
NominalLendingFee
0.01
mnkd Percentage Of Credit Exchange Receivable
PercentageOfCreditExchangeReceivable
0.65 pure
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
40499000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
12614000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9667000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
63506000
us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
35900000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47752000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1567000
us-gaap Share Based Compensation
ShareBasedCompensation
51583000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1435000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
20000000
mnkd Number Of Employees With Modified Equity Based Compensation Awards
NumberOfEmployeesWithModifiedEquityBasedCompensationAwards
124 Employee
mnkd Non Cash Financing Activities Loan Commitment Asset
NonCashFinancingActivitiesLoanCommitmentAsset
1753000
mnkd Amortization Period Of Lease Hold Improvements
AmortizationPeriodOfLeaseHoldImprovements
P4Y
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
3331000
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
us-gaap Operating Income Loss
OperatingIncomeLoss
-2341924000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2421828000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-165000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
20622000
mnkd Write Off Of Derivative Liability
WriteOffOfDerivativeLiability
363000
mnkd Reclassification Of Share Based Awards To Liability
ReclassificationOfShareBasedAwardsToLiability
19926000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1800000000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1785401000
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1237000
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
70000000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
796779000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000
us-gaap Available For Sale Securities Gross Realized Gain Loss Net
AvailableForSaleSecuritiesGrossRealizedGainLossNet
-990000
us-gaap Sales Revenue Net
SalesRevenueNet
3166000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1746000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
361000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2422206000
us-gaap Income Taxes Paid
IncomeTaxesPaid
26000
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
100000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1028000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
598000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9162000
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-4000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1667000
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
115000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
345400000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1101000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2445036000
us-gaap Net Income Loss
NetIncomeLoss
-2421824000
us-gaap Investment Income Interest
InvestmentIncomeInterest
37006000
us-gaap Interest Paid
InterestPaid
77900000
us-gaap Stock Issued1
StockIssued1
2758000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
17951000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
48000
us-gaap Interest Paid Capitalized
InterestPaidCapitalized
22105000
us-gaap Construction In Progress Expenditures Incurred But Not Yet Paid
ConstructionInProgressExpendituresIncurredButNotYetPaid
2965000
us-gaap Operating Expenses
OperatingExpenses
2345090000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
119500000
us-gaap Interest Expense Debt
InterestExpenseDebt
61557000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
46569000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
41214000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
35409000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-382000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3460000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
1742000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
952000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
153448000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
2171947000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3900000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
454000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
19726000
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
5248000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
151428000
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
6494000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-345332000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
15000000
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
387750000
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
1640798000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
207050000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
533138000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4914000
us-gaap Preferred Stock Conversions Inducements
PreferredStockConversionsInducements
22260000
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
4220000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
796393000
us-gaap Share Based Compensation
ShareBasedCompensation
234687000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2024000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
48000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
20000000
mnkd Collection Of Convertible Preferred Stock Subscriptions Receivable
CollectionOfConvertiblePreferredStockSubscriptionsReceivable
50000000
mnkd Accrued Interest On Investments Net Of Amortization Of Discounts
AccruedInterestOnInvestmentsNetOfAmortizationOfDiscounts
191000
mnkd Issuance Of Redeemable Convertible Preferred Stock
IssuanceOfRedeemableConvertiblePreferredStock
4296000
mnkd Put Shares Sold To Majority Stockholder
PutSharesSoldToMajorityStockholder
623000
mnkd Non Cash Financing Activities Loan Commitment Asset
NonCashFinancingActivitiesLoanCommitmentAsset
1753000
mnkd Issuance Of Convertible Preferred Stock Subscriptions
IssuanceOfConvertiblePreferredStockSubscriptions
50000000
mnkd Forward Purchase Contract Contribution To Additional Paid In Capital
ForwardPurchaseContractContributionToAdditionalPaidInCapital
29317000
mnkd Issuance Of Put Option By Stockholder
IssuanceOfPutOptionByStockholder
2949000
mnkd Put Option Redemption By Stockholder
PutOptionRedemptionByStockholder
1921000
mnkd Reclassification Of Forward Purchase Contract To Additional Paid In Capital
ReclassificationOfForwardPurchaseContractToAdditionalPaidInCapital
28080000
mnkd Cancellation Of Principal On Note Payable To Related Party
CancellationOfPrincipalOnNotePayableToRelatedParty
290334000
mnkd State Research And Development Credit Exchange Receivable
StateResearchAndDevelopmentCreditExchangeReceivable
-462000
mnkd Stock Expense For Shares Issued Pursuant To Research Agreement
StockExpenseForSharesIssuedPursuantToResearchAgreement
3018000
mnkd Gain Loss On Sale Abandonment Disposal Or Impairment Of Property And Equipment
GainLossOnSaleAbandonmentDisposalOrImpairmentOfPropertyAndEquipment
-25070000
mnkd Increase In Additional Paid In Capital Resulting From Merger
IncreaseInAdditionalPaidInCapitalResultingFromMerger
171154000
mnkd Proceeds From Issuance Of Common Stock And Warrants Net
ProceedsFromIssuanceOfCommonStockAndWarrantsNet
1564946000
mnkd Write Off Of Derivative Liability
WriteOffOfDerivativeLiability
363000
mnkd Reclassification Of Share Based Awards To Liability
ReclassificationOfShareBasedAwardsToLiability
19926000
CY2014Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
17700 shares
CY2014Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
46400 shares
CY2013Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
284044000 shares
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2013Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46124000
CY2013Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
CY2013Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-41585000
CY2013Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-46124000
CY2013Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
15000
CY2013Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-46124000
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-46124000
CY2013Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2013Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10172000
CY2013Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2956000
CY2013Q2 us-gaap Operating Expenses
OperatingExpenses
41585000
CY2013Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1689000
CY2013Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
212000
CY2013Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2866000
CY2013Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
27052000
CY2013Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14533000
CY2014Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
252600 shares
CY2014Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
380770000 shares
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.19
CY2014Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
158600 shares
CY2014Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-73365000
CY2014Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
CY2014Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-69846000
CY2014Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-73365000
CY2014Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-370000
CY2014Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-73365000
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-73365000
CY2014Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000
CY2014Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
40644000
CY2014Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2449000
CY2014Q2 us-gaap Operating Expenses
OperatingExpenses
69846000
CY2014Q2 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
721000
CY2014Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
227000
CY2014Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
2429000
CY2014Q2 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
37323000
CY2014Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
32523000

Files In Submission

Name View Source Status
0001193125-14-305043-index-headers.html Edgar Link pending
0001193125-14-305043-index.html Edgar Link pending
0001193125-14-305043.txt Edgar Link pending
0001193125-14-305043-xbrl.zip Edgar Link pending
d737392d10q.htm Edgar Link pending
d737392dex311.htm Edgar Link pending
d737392dex312.htm Edgar Link pending
d737392dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
mnkd-20140630.xml Edgar Link completed
mnkd-20140630.xsd Edgar Link pending
mnkd-20140630_cal.xml Edgar Link unprocessable
mnkd-20140630_def.xml Edgar Link unprocessable
mnkd-20140630_lab.xml Edgar Link unprocessable
mnkd-20140630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending